In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate

You-Meei Lin1, Jui-Yu Wu2, Ying-Chen Chen3, Yu-Der Su3, Wen-Tin Ke3, Hsiu-O Ho31Department of Pharmacy, Shuang Ho Hospital, 2Department of Biochemistry, School of Medicine, 3School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, ROCObjectives: In situ formation of nanocr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lin YM, Wu JU, Chen YC, Su YD, Ke WT, Ho HO, Sheu MT
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/9719d0abdf584daea68691c30136875e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9719d0abdf584daea68691c30136875e
record_format dspace
spelling oai:doaj.org-article:9719d0abdf584daea68691c30136875e2021-12-02T00:40:26ZIn situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate1176-91141178-2013https://doaj.org/article/9719d0abdf584daea68691c30136875e2011-10-01T00:00:00Zhttp://www.dovepress.com/in-situ-formation-of-nanocrystals-from-a-self-microemulsifying-drug-de-a8495https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013You-Meei Lin1, Jui-Yu Wu2, Ying-Chen Chen3, Yu-Der Su3, Wen-Tin Ke3, Hsiu-O Ho31Department of Pharmacy, Shuang Ho Hospital, 2Department of Biochemistry, School of Medicine, 3School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, ROCObjectives: In situ formation of nanocrystals and dissolution profiles of fenofibrate (FFB) from a self-microemulsifying drug delivery system (SMEDDS) were characterized.Methods: SMEDDS formulated with Myritol® and surfactant mixture (Smix) of D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) and either Tween® 20 (A, C, E, G, M, S, N, T, O) or Tween® 80 (B, D, F, H, P, U, Q, V, R) at various oil/Smix ratios (Group I: A and B of 0.42, C and D of 0.25, E and F of 0.11; Group II: G and H of 1.38, M and P of 1.11, S and U of 0.9, N and Q of 0.73, T and V of 0.58, and O and R of 0.46) and water contents (1: 9.5%, 2: 5.0%, 3: 0.0%, G-V: 4.5%). Their dissolutions were conducted at different rotation speeds. Two optimal SMEDDSs containing Tween 80(B2) or a higher oil/Smix ratio(Q) and B2(solution) were selected for pharmacokinetic study.Results: FFB particles formed within the nanosize range from Group I gradually increased with time but decreased with increasing stirring rates. However, the mean size of FFB formed by B series was as low as 200 nm, which was smaller than that of A series at three stirring rates. The release rate from both groups obviously increased with increasing stirring rate. However, incomplete release was observed for S and N in Tween 20 series, whereas a faster release rate and complete release were observed for Tween 80 series with an insignificant difference among them. Results of pharmacokinetic study demonstrated that the highest-ranked area under the curve and Cmax values were for Q(SMEDDS) and B2(solution), respectively. The relative bioavailability of Q(SMEDDS) with respect to Tricor® was enhanced by about 1.14-1.22-fold.Conclusion: SMEDDS, consisting of Myritol 318 and TPGS combined with Tween 80 at 4:1, was able to enhance the oral bioavailability of FFB.Keywords: SMEDDS, fenofibrate, microemulsion, dissolution, TPGSLin YMWu JUChen YCSu YDKe WTHo HOSheu MTDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2011, Iss default, Pp 2445-2457 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Lin YM
Wu JU
Chen YC
Su YD
Ke WT
Ho HO
Sheu MT
In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
description You-Meei Lin1, Jui-Yu Wu2, Ying-Chen Chen3, Yu-Der Su3, Wen-Tin Ke3, Hsiu-O Ho31Department of Pharmacy, Shuang Ho Hospital, 2Department of Biochemistry, School of Medicine, 3School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, ROCObjectives: In situ formation of nanocrystals and dissolution profiles of fenofibrate (FFB) from a self-microemulsifying drug delivery system (SMEDDS) were characterized.Methods: SMEDDS formulated with Myritol® and surfactant mixture (Smix) of D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) and either Tween® 20 (A, C, E, G, M, S, N, T, O) or Tween® 80 (B, D, F, H, P, U, Q, V, R) at various oil/Smix ratios (Group I: A and B of 0.42, C and D of 0.25, E and F of 0.11; Group II: G and H of 1.38, M and P of 1.11, S and U of 0.9, N and Q of 0.73, T and V of 0.58, and O and R of 0.46) and water contents (1: 9.5%, 2: 5.0%, 3: 0.0%, G-V: 4.5%). Their dissolutions were conducted at different rotation speeds. Two optimal SMEDDSs containing Tween 80(B2) or a higher oil/Smix ratio(Q) and B2(solution) were selected for pharmacokinetic study.Results: FFB particles formed within the nanosize range from Group I gradually increased with time but decreased with increasing stirring rates. However, the mean size of FFB formed by B series was as low as 200 nm, which was smaller than that of A series at three stirring rates. The release rate from both groups obviously increased with increasing stirring rate. However, incomplete release was observed for S and N in Tween 20 series, whereas a faster release rate and complete release were observed for Tween 80 series with an insignificant difference among them. Results of pharmacokinetic study demonstrated that the highest-ranked area under the curve and Cmax values were for Q(SMEDDS) and B2(solution), respectively. The relative bioavailability of Q(SMEDDS) with respect to Tricor® was enhanced by about 1.14-1.22-fold.Conclusion: SMEDDS, consisting of Myritol 318 and TPGS combined with Tween 80 at 4:1, was able to enhance the oral bioavailability of FFB.Keywords: SMEDDS, fenofibrate, microemulsion, dissolution, TPGS
format article
author Lin YM
Wu JU
Chen YC
Su YD
Ke WT
Ho HO
Sheu MT
author_facet Lin YM
Wu JU
Chen YC
Su YD
Ke WT
Ho HO
Sheu MT
author_sort Lin YM
title In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
title_short In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
title_full In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
title_fullStr In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
title_full_unstemmed In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
title_sort in situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/9719d0abdf584daea68691c30136875e
work_keys_str_mv AT linym insituformationofnanocrystalsfromaselfmicroemulsifyingdrugdeliverysystemtoenhanceoralbioavailabilityoffenofibrate
AT wuju insituformationofnanocrystalsfromaselfmicroemulsifyingdrugdeliverysystemtoenhanceoralbioavailabilityoffenofibrate
AT chenyc insituformationofnanocrystalsfromaselfmicroemulsifyingdrugdeliverysystemtoenhanceoralbioavailabilityoffenofibrate
AT suyd insituformationofnanocrystalsfromaselfmicroemulsifyingdrugdeliverysystemtoenhanceoralbioavailabilityoffenofibrate
AT kewt insituformationofnanocrystalsfromaselfmicroemulsifyingdrugdeliverysystemtoenhanceoralbioavailabilityoffenofibrate
AT hoho insituformationofnanocrystalsfromaselfmicroemulsifyingdrugdeliverysystemtoenhanceoralbioavailabilityoffenofibrate
AT sheumt insituformationofnanocrystalsfromaselfmicroemulsifyingdrugdeliverysystemtoenhanceoralbioavailabilityoffenofibrate
_version_ 1718403570946015232